Literature DB >> 22905729

Incorporating gold into nanocrystalline silver dressings reduces grain boundary size and maintains suitable antimicrobial properties.

Kevin R Unrau1, Marion H Cavanagh2, On Kwan Cheng2, Shiman Wang2, Robert E Burrell2.   

Abstract

Nanocrystalline silver dressings are widely known to be potent antimicrobial and anti-inflammatory agents and have long been used to treat topical wounds. Gold is known to be a strong anti-inflammatory agent and has been used in the treatment of rheumatoid arthritis for >70 years. The purpose of this work was to study the effect of incorporating gold into nanocrystalline silver dressings from antimicrobial and anti-inflammatory perspectives. Gold and silver dressing alloys were created by direct current magnetron sputtering and compared with pure silver nanocrystalline dressings using conventional biological (log reduction and corrected zone of inhibition) and physical (X-ray diffraction, X-ray photoelectron spectroscopy, energy-dispersive X-ray spectroscopy, atomic absorption spectroscopy, atomic force microscopy and scanning electron microscopy) characterisation techniques. While the gold/silver dressings were slightly weaker antimicrobials than the pure silver nanocrystalline structures, the addition of gold to the nanostructure reduces the minimum crystallite size from 17 to 4 nm. This difference increases the number of grain boundary atoms from 12% to 40% which could augment the anti-inflammatory properties of the dressings. The formation of gold oxide (Au2O3) was thought to be responsible for the observed decrease in crystallite size.
© 2012 The Authors. International Wound Journal © 2012 John Wiley & Sons Ltd and Medicalhelplines.com Inc.

Entities:  

Keywords:  Antimicrobial; Grain boundary; Nanogold; Nanosilver; Wound dressing

Mesh:

Substances:

Year:  2012        PMID: 22905729      PMCID: PMC7950740          DOI: 10.1111/j.1742-481X.2012.01042.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  12 in total

1.  Waste water bacterial isolates resistant to heavy metals and antibiotics.

Authors:  B K Filali; J Taoufik; Y Zeroual; F Z Dzairi; M Talbi; M Blaghen
Journal:  Curr Microbiol       Date:  2000-09       Impact factor: 2.188

2.  In vitro cytotoxity of silver: implication for clinical wound care.

Authors:  Vincent K M Poon; Andrew Burd
Journal:  Burns       Date:  2004-03       Impact factor: 2.744

3.  Particulate gold as an anti-inflammatory mediator in bone allograft---an animal study.

Authors:  Kasra Zainali; Jorgen Baas; Thomas Jakobsen; Gorm Danscher; Kjeld Soballe
Journal:  J Biomed Mater Res A       Date:  2010-12-01       Impact factor: 4.396

4.  Does nanocrystalline silver have a transferable effect?

Authors:  Patricia L Nadworny; Breanne K Landry; JianFei Wang; Edward E Tredget; Robert E Burrell
Journal:  Wound Repair Regen       Date:  2010-03-12       Impact factor: 3.617

5.  Impact of heat on nanocrystalline silver dressings. Part II: Physical properties.

Authors:  P L Taylor; O Omotoso; J B Wiskel; D Mitlin; R E Burrell
Journal:  Biomaterials       Date:  2005-12       Impact factor: 12.479

6.  A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.

Authors:  Yuesheng Huang; Xiaolu Li; Zhenjiang Liao; Guoan Zhang; Qun Liu; Jin Tang; Yizhi Peng; Xuesheng Liu; Qizhi Luo
Journal:  Burns       Date:  2006-12-18       Impact factor: 2.744

7.  Treatment of severe burns with aqueous silver nitrate (0.5 percent).

Authors:  H C Polk
Journal:  Ann Surg       Date:  1966-10       Impact factor: 12.969

8.  Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis.

Authors:  Kailash C Bhol; Paul J Schechter
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

9.  Introduction to metallic nanoparticles.

Authors:  Vicky V Mody; Rodney Siwale; Ajay Singh; Hardik R Mody
Journal:  J Pharm Bioallied Sci       Date:  2010-10

Review 10.  Chrysotherapy: a synoptic review.

Authors:  R Eisler
Journal:  Inflamm Res       Date:  2003-11-13       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.